The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositis
Alexander Oldroyd(Manchester Academic Health Science Centre), Dennis McGonagle(Leeds General Infirmary), Bridget Griffiths(Freeman Hospital), William Ollier(University of Manchester), Robert G. Cooper(McMaster University), Jamie C. Sergeant(Manchester Academic Health Science Centre), Raashid Luqmani(Nuffield Orthopaedic Centre), Paul Emery(University of Leeds), Michael F. Martin, Sally Knights, J. L. A. Fordham(University College London), E G Chelliah, Beverley Harrison(University of Manchester), P S Klimiuk, Simon Bowman(University Hospitals Birmingham NHS Foundation Trust), John D. Isaacs(Newcastle upon Tyne Hospitals NHS Foundation Trust), Ian N Bruce(University of Manchester), Fiona Clarke, Yasmeen Ahmed, John Carty, Peter Lanyon(Nottingham University Hospitals NHS Trust), Sanjeet Kamath, Hector Chinoy(Salford Royal NHS Foundation Trust), Bryan Lecky, Neil McHugh(University of Bath), Janine A. Lamb(University of Manchester), Chandra Chattopadhyay, Elaine M. Hay(Arthritis UK), Lesley Horden, Christopher Edwards(University of Liverpool), Thomas J. Kennedy, Alexander Fraser, Harsha Gunawardena, Adrian Jones, Robert Bernstein, Paul New(University of Liverpool), Zoë Betteridge(University of Bath), Jeffrey M. Marks(University Hospitals of Cleveland), Ramasharan Laxminarayan, Hill Gaston, Raymond Armstrong(University of Liverpool), Robin Butler, P. T. Dawes, Joseph Devlin, Carol M. Black, Frances Hall, George D. Kitas(Russells Hall Hospital), John Lambert, Patrick Gordon
Cited by 110
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
|Annals of the Rheumatic Diseases|2019|1.1k
EULAR recommendations for the management of primary small and medium vessel vasculitis
|Annals of the Rheumatic Diseases|2008|986